Caplin Point Laboratories Ltd Quarterly Results

Gross Sales

510.22

502.45

492.96

483.1

458.96

Excise Duty

0

0

0

0

0

Net Sales

510.22

502.45

492.96

483.1

458.96

Other Operating Income

0

0

0

0

0

Other Income

23.17

25.82

31.36

20.77

18.58

Total Income

533.39

528.27

524.32

503.87

477.54

Total Expenditure

332.46

334.39

330.68

318.44

307.15

PBIDT

200.93

193.88

193.64

185.43

170.39

Interest

0.18

0.17

0.18

0.21

0.05

PBDT

200.75

193.71

193.46

185.22

170.34

Depreciation

16.29

17.04

16.2

16.76

15.96

Minority Interest Before NP

0

0

0

0

0

Tax

33.1

29.27

34.22

32.46

29.38

Deferred Tax

0.6

2.12

2.97

5.19

0.08

Reported Profit After Tax

150.76

145.28

140.07

130.81

124.92

Minority Interest After NP

-2.04

2.71

1.11

0.01

0.95

Net Profit after Minority Interest

152.8

142.57

138.96

130.8

123.97

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

152.8

142.57

138.96

130.8

123.97

EPS (Unit Curr.)

20.1

18.75

18.28

17.22

16.32

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

125

Equity

15.2

15.2

15.2

15.2

15.2

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

39.38

38.58

39.28

38.38

37.12

PBDTM(%)

39.34

38.55

39.24

38.33

37.11

PATM(%)

29.54

28.91

28.41

27.07

27.21